table of content
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnostic Biomarkers
1.2.3 Predictive Biomarkers
1.2.4 Prognostic Biomarkers
1.3 Market by Application
1.3.1 Global Clinical Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research and Academic Laboratories
1.3.3 Biopharmaceutical and Biotech Companies
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarkers Market Perspective (2017-2028)
2.2 Clinical Biomarkers Growth Trends by Region
2.2.1 Clinical Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Clinical Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Clinical Biomarkers Market Dynamics
2.3.1 Clinical Biomarkers Industry Trends
2.3.2 Clinical Biomarkers Market Drivers
2.3.3 Clinical Biomarkers Market Challenges
2.3.4 Clinical Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarkers Players by Revenue
3.1.1 Global Top Clinical Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Clinical Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarkers Revenue
3.4 Global Clinical Biomarkers Market Concentration Ratio
3.4.1 Global Clinical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarkers Revenue in 2021
3.5 Clinical Biomarkers Key Players Head office and Area Served
3.6 Key Players Clinical Biomarkers Product Solution and Service
3.7 Date of Enter into Clinical Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarkers Breakdown Data by Type
4.1 Global Clinical Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Clinical Biomarkers Forecasted Market Size by Type (2023-2028)
5 Clinical Biomarkers Breakdown Data by Application
5.1 Global Clinical Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Clinical Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Biomarkers Market Size (2017-2028)
6.2 North America Clinical Biomarkers Market Size by Type
6.2.1 North America Clinical Biomarkers Market Size by Type (2017-2022)
6.2.2 North America Clinical Biomarkers Market Size by Type (2023-2028)
6.2.3 North America Clinical Biomarkers Market Share by Type (2017-2028)
6.3 North America Clinical Biomarkers Market Size by Application
6.3.1 North America Clinical Biomarkers Market Size by Application (2017-2022)
6.3.2 North America Clinical Biomarkers Market Size by Application (2023-2028)
6.3.3 North America Clinical Biomarkers Market Share by Application (2017-2028)
6.4 North America Clinical Biomarkers Market Size by Country
6.4.1 North America Clinical Biomarkers Market Size by Country (2017-2022)
6.4.2 North America Clinical Biomarkers Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Biomarkers Market Size (2017-2028)
7.2 Europe Clinical Biomarkers Market Size by Type
7.2.1 Europe Clinical Biomarkers Market Size by Type (2017-2022)
7.2.2 Europe Clinical Biomarkers Market Size by Type (2023-2028)
7.2.3 Europe Clinical Biomarkers Market Share by Type (2017-2028)
7.3 Europe Clinical Biomarkers Market Size by Application
7.3.1 Europe Clinical Biomarkers Market Size by Application (2017-2022)
7.3.2 Europe Clinical Biomarkers Market Size by Application (2023-2028)
7.3.3 Europe Clinical Biomarkers Market Share by Application (2017-2028)
7.4 Europe Clinical Biomarkers Market Size by Country
7.4.1 Europe Clinical Biomarkers Market Size by Country (2017-2022)
7.4.2 Europe Clinical Biomarkers Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Clinical Biomarkers Market Size by Type
8.2.1 Asia-Pacific Clinical Biomarkers Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical Biomarkers Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical Biomarkers Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical Biomarkers Market Size by Application
8.3.1 Asia-Pacific Clinical Biomarkers Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical Biomarkers Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical Biomarkers Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical Biomarkers Market Size by Region
8.4.1 Asia-Pacific Clinical Biomarkers Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical Biomarkers Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Biomarkers Market Size (2017-2028)
9.2 Latin America Clinical Biomarkers Market Size by Type
9.2.1 Latin America Clinical Biomarkers Market Size by Type (2017-2022)
9.2.2 Latin America Clinical Biomarkers Market Size by Type (2023-2028)
9.2.3 Latin America Clinical Biomarkers Market Share by Type (2017-2028)
9.3 Latin America Clinical Biomarkers Market Size by Application
9.3.1 Latin America Clinical Biomarkers Market Size by Application (2017-2022)
9.3.2 Latin America Clinical Biomarkers Market Size by Application (2023-2028)
9.3.3 Latin America Clinical Biomarkers Market Share by Application (2017-2028)
9.4 Latin America Clinical Biomarkers Market Size by Country
9.4.1 Latin America Clinical Biomarkers Market Size by Country (2017-2022)
9.4.2 Latin America Clinical Biomarkers Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Clinical Biomarkers Market Size by Type
10.2.1 Middle East & Africa Clinical Biomarkers Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical Biomarkers Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical Biomarkers Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical Biomarkers Market Size by Application
10.3.1 Middle East & Africa Clinical Biomarkers Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical Biomarkers Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical Biomarkers Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical Biomarkers Market Size by Country
10.4.1 Middle East & Africa Clinical Biomarkers Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical Biomarkers Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarkers Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarkers Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Clinical Biomarkers Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.2.5 Agilent Technologies, Inc. Recent Developments
11.3 ALCEDIAG
11.3.1 ALCEDIAG Company Details
11.3.2 ALCEDIAG Business Overview
11.3.3 ALCEDIAG Clinical Biomarkers Introduction
11.3.4 ALCEDIAG Revenue in Clinical Biomarkers Business (2017-2022)
11.3.5 ALCEDIAG Recent Developments
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Details
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Clinical Biomarkers Introduction
11.4.4 Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2017-2022)
11.4.5 Becton, Dickinson and Company Recent Developments
11.5 bioM?rieux S.A.
11.5.1 bioM?rieux S.A. Company Details
11.5.2 bioM?rieux S.A. Business Overview
11.5.3 bioM?rieux S.A. Clinical Biomarkers Introduction
11.5.4 bioM?rieux S.A. Revenue in Clinical Biomarkers Business (2017-2022)
11.5.5 bioM?rieux S.A. Recent Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Details
11.6.2 Bio-Rad Laboratories, Inc. Business Overview
11.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Introduction
11.6.4 Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.6.5 Bio-Rad Laboratories, Inc. Recent Developments
11.7 CENTOGENE N.V.
11.7.1 CENTOGENE N.V. Company Details
11.7.2 CENTOGENE N.V. Business Overview
11.7.3 CENTOGENE N.V. Clinical Biomarkers Introduction
11.7.4 CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2017-2022)
11.7.5 CENTOGENE N.V. Recent Developments
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2017-2022)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.9 Enzo Biochem Inc.
11.9.1 Enzo Biochem Inc. Company Details
11.9.2 Enzo Biochem Inc. Business Overview
11.9.3 Enzo Biochem Inc. Clinical Biomarkers Introduction
11.9.4 Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.9.5 Enzo Biochem Inc. Recent Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Clinical Biomarkers Introduction
11.10.4 Illumina, Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.10.5 Illumina, Inc. Recent Developments
11.11 Myriad Genetics, Inc.
11.11.1 Myriad Genetics, Inc. Company Details
11.11.2 Myriad Genetics, Inc. Business Overview
11.11.3 Myriad Genetics, Inc. Clinical Biomarkers Introduction
11.11.4 Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.11.5 Myriad Genetics, Inc. Recent Developments
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2017-2022)
11.12.5 Quest Diagnostics Incorporated Recent Developments
11.13 QIAGEN N.V.
11.13.1 QIAGEN N.V. Company Details
11.13.2 QIAGEN N.V. Business Overview
11.13.3 QIAGEN N.V. Clinical Biomarkers Introduction
11.13.4 QIAGEN N.V. Revenue in Clinical Biomarkers Business (2017-2022)
11.13.5 QIAGEN N.V. Recent Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2017-2022)
11.14.5 Thermo Fisher Scientific Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
